These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 14504414)

  • 1. Association of muscarinic m1 receptor genetic polymorphisms with psychiatric symptoms and cognitive function in schizophrenic patients.
    Liao DL; Hong CJ; Chen HM; Chen YE; Lee SM; Chang CY; Chen H; Tsai SJ
    Neuropsychobiology; 2003; 48(2):72-6. PubMed ID: 14504414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Muscarinic M1 receptor sequence: preliminary studies on its effects on cognition and expression.
    Scarr E; Sundram S; Deljo A; Cowie TF; Gibbons AS; Juzva S; Mackinnon A; Wood SJ; Testa R; Pantelis C; Dean B
    Schizophr Res; 2012 Jun; 138(1):94-8. PubMed ID: 22391213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prefrontal cognition in schizophrenia and bipolar illness in relation to Val66Met polymorphism of the brain-derived neurotrophic factor gene.
    Rybakowski JK; Borkowska A; Skibinska M; Szczepankiewicz A; Kapelski P; Leszczynska-Rodziewicz A; Czerski PM; Hauser J
    Psychiatry Clin Neurosci; 2006 Feb; 60(1):70-6. PubMed ID: 16472361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of a muscarinic receptor 1 gene variant on grey matter volume in schizophrenia.
    Cropley VL; Scarr E; Fornito A; Klauser P; Bousman CA; Scott R; Cairns MJ; Tooney PA; Pantelis C; Dean B
    Psychiatry Res; 2015 Nov; 234(2):182-7. PubMed ID: 26481978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of a muscarinic receptor 1 gene variant on executive and non-executive cognition in schizophrenia spectrum disorders.
    Carruthers SP; Cropley V; Bousman C; Everall IP; Neill E; Pantelis C; Sumner PJ; Tan EJ; ; Bozaoglu K; Thomas EHX; Van Rheenen TE; Gurvich CT; Rossell SL
    Psychiatry Res; 2019 Mar; 273():178-180. PubMed ID: 30654302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association analysis for the muscarinic M1 receptor genetic polymorphisms and Alzheimer's disease.
    Liu HC; Hong CJ; Liu TY; Chi CW; Tsai SJ
    Dement Geriatr Cogn Disord; 2005; 19(1):42-5. PubMed ID: 15383745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphisms of the Fyn kinase gene and a performance on the Wisconsin Card Sorting Test in schizophrenia.
    Rybakowski JK; Borkowska A; Skibinska M; Hauser J
    Psychiatr Genet; 2007 Jun; 17(3):201-4. PubMed ID: 17417065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COMT genotype is associated with differential expression of muscarinic M1 receptors in human cortex.
    Dean B; Scarr E
    Am J Med Genet B Neuropsychiatr Genet; 2016 Sep; 171(6):784-9. PubMed ID: 26954460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance on the Wisconsin Card Sorting Test in schizophrenia and genes of dopaminergic inactivation (COMT, DAT, NET).
    Rybakowski JK; Borkowska A; Czerski PM; Dmitrzak-Weglarz M; Skibinska M; Kapelski P; Hauser J
    Psychiatry Res; 2006 Jun; 143(1):13-9. PubMed ID: 16712949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An association study of dopamine receptors polymorphisms and the Wisconsin Card Sorting Test in schizophrenia.
    Rybakowski JK; Borkowska A; Czerski PM; Kapelski P; Dmitrzak-Weglarz M; Hauser J
    J Neural Transm (Vienna); 2005 Nov; 112(11):1575-82. PubMed ID: 15785860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of the Cholinergic Muscarinic M2 Receptor with Autonomic Nervous System Activity in Patients with Schizophrenia on High-Dose Antipsychotics.
    Miyauchi M; Kishida I; Suda A; Shiraishi Y; Hattori S; Fujibayashi M; Taguri M; Ishii C; Ishii N; Moritani T; Hirayasu Y
    Neuropsychobiology; 2016; 74(1):60-67. PubMed ID: 27923235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TCF4 gene polymorphism is associated with cognition in patients with schizophrenia and healthy controls.
    Hui L; Rao WW; Yu Q; Kou C; Wu JQ; He JC; Ye MJ; Liu JH; Xu XJ; Zheng K; Ruan LN; Liu HY; Hu WM; Shao TN; AngRabanes MB; Soares JC; Zhang XY
    J Psychiatr Res; 2015 Oct; 69():95-101. PubMed ID: 26343600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Smoking in chronic schizophrenic inpatients in taiwan.
    Liao DL; Yang JY; Lee SM; Chen H; Tsai SJ
    Neuropsychobiology; 2002; 45(4):172-5. PubMed ID: 12097804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risperidone treatment of schizophrenia: improvement in psychopathology and neuropsychological tests.
    Borkowska A; Araszkiewicz A; Rajewski A; Rybakowski JK
    Neuropsychobiology; 2002; 46(2):85-9. PubMed ID: 12378125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-dose of multiple antipsychotics and cognitive function in schizophrenia: the effect of dose-reduction.
    Kawai N; Yamakawa Y; Baba A; Nemoto K; Tachikawa H; Hori T; Asada T; Iidaka T
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Aug; 30(6):1009-14. PubMed ID: 16644082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T102C polymorphisms at the 5-HT2A receptor gene in Turkish schizophrenia patients: a possible association with prognosis.
    Herken H; Erdal ME; Erdal N; Aynacioglu S
    Neuropsychobiology; 2003; 47(1):27-30. PubMed ID: 12606842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modification of cognitive performance in schizophrenia by complexin 2 gene polymorphisms.
    Begemann M; Grube S; Papiol S; Malzahn D; Krampe H; Ribbe K; Friedrichs H; Radyushkin KA; El-Kordi A; Benseler F; Hannke K; Sperling S; Schwerdtfeger D; Thanhäuser I; Gerchen MF; Ghorbani M; Gutwinski S; Hilmes C; Leppert R; Ronnenberg A; Sowislo J; Stawicki S; Stödtke M; Szuszies C; Reim K; Riggert J; Eckstein F; Falkai P; Bickeböller H; Nave KA; Brose N; Ehrenreich H
    Arch Gen Psychiatry; 2010 Sep; 67(9):879-88. PubMed ID: 20819981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship of common variants in CHRNA5 with early-onset schizophrenia and executive function.
    Han W; Zhang T; Ni T; Zhu L; Liu D; Chen G; Lin H; Chen T; Guan F
    Schizophr Res; 2019 Apr; 206():407-412. PubMed ID: 30366711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Triiodothyronine may be possibly associated with better cognitive function and less extrapyramidal symptoms in chronic schizophrenia.
    Ichioka S; Terao T; Hoaki N; Matsushita T; Hoaki T
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Oct; 39(1):170-4. PubMed ID: 22750309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between BDNF Val66Met polymorphism and cognitive performance in antipsychotic-naïve patients with schizophrenia.
    Lu W; Zhang C; Yi Z; Li Z; Wu Z; Fang Y
    J Mol Neurosci; 2012 Jul; 47(3):505-10. PubMed ID: 22477643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.